How much funding has SIBIONICS raised?

SIBIONICS has raised $260.0M in total funding, most recently a Series D round.

Where is SIBIONICS headquartered?

SIBIONICS is headquartered in Shenzhen, China.

What industry is SIBIONICS in?

SIBIONICS operates in Healthcare, Medical Devices, Biosensors.

How many employees does SIBIONICS have?

SIBIONICS has 201-500 employees.

SIBIONICS

Q: Who are SIBIONICS's investors?

SIBIONICS's investors include Shanghai Biomedical Industrial Equity Investment Fund.

Digital hospital-wide blood glucose management solutions --SIBIONICS® CGM

Shenzhen, China · Founded 2015 · $260.0M raised

Healthcare

Medical Devices

Biosensors

Headquarters: Shenzhen
Employees: 201–500
Founded: 2015
Business Model: B2B2C

Website: en.sibionics.com
Total Funding: $260.0M
Last Round: $72.0M Series DDec 2022
Rounds: 3

About

SIBIONICS (Silicon Bionic) is a Shenzhen-based medical device company founded in 2015, focused on chronic disease management technologies. Its flagship CGM System received CE Mark approval in 2023. SIBIONICS also develops the eye-si AI fundus screening system, approved in China in 2020. The company employs over 700 individuals with more than 40% in R&D.

Summary

SIBIONICS is a Healthcare company based in Shenzhen, China, founded in 2015. It has raised $260.0M in total across 3 rounds, most recently a $72.0M Series D round in Dec 2022. Investors include Shanghai Biomedical Industrial Equity Investment Fund.